STOCK TITAN

Yarrow Bioscience: Logos Global reports 9.99% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

For Yarrow Bioscience, Inc. (YARW), an amended Schedule 13G reports shared beneficial ownership of its common stock as of September 30, 2026. Logos Global Management LP, its general partner Logos Global Management GP LLC, and control person William Arsani each reported 1,007,511 shares (9.99%). Logos Opportunities Fund V LP, its general partner Logos Opportunities V GP LLC, and control person Graham Walmsley each reported 957,511 shares (9.5%). Logos Global Master Fund LP and its general partner Logos GP LLC each reported 489,354 shares (4.9%). These are separately reported positions across related entities and people.

The stated positions include common shares and prefunded warrants to acquire additional shares, subject to a 9.99% beneficial ownership limitation. The percentages use 9,437,693 common shares outstanding following the closing of the offering described in the prospectus filed September 11, 2026. The reporting persons filed jointly but disclaimed group membership and beneficial ownership except to the extent of their pecuniary interests.

Reported beneficial ownership 1,007,511 shares (9.99%) Reported for Logos Global Management LP, Logos Global Management GP LLC and William Arsani.
Reported beneficial ownership 957,511 shares (9.5%) Reported for Logos Opportunities Fund V LP, Logos Opportunities V GP LLC and Graham Walmsley.
Reported beneficial ownership 489,354 shares (4.9%) Reported for Logos Global Master Fund LP and Logos GP LLC.
Shares outstanding 9,437,693 shares Following the closing of the offering described in the prospectus filed September 11, 2026.
Beneficial ownership limitation 9.99% The reported positions are subject to this limitation.
Prefunded warrants 1,267,556 shares Shares the warrants may acquire; reported for Logos Global and William Arsani.
Prefunded warrants 828,202 shares Shares the warrants may acquire; reported for Opportunities Fund V and Graham Walmsley.
Prefunded warrants 439,354 shares Shares the warrants may acquire; reported for Global Master Fund.
prefunded warrants technical
"prefunded warrants to acquire 1,267,556 shares of Common Stock"
Prefunded warrants are a security that gives the holder the right to convert the warrant into a share after paying a very small remaining amount because almost the full purchase price was paid upfront. They matter to investors because exercising them increases the company’s outstanding shares (dilution) and can provide immediate cash to the issuer while allowing holders to bypass ownership limits or simplify timing, similar to buying a nearly-complete gift card that only needs a tiny top-up to use.
beneficial ownership limitation regulatory
"subject to a 9.99% beneficial ownership limitation"
A beneficial ownership limitation is a rule that caps the percentage of a company’s shares an investor can be treated as owning or controlling for voting, regulatory or tax purposes. It matters to investors because it can restrict how many shares a person or group can buy or vote, affect takeover chances, and influence share liquidity and value — like a speed limit that prevents any single driver from taking over the whole road.
shared dispositive power regulatory
"Shared Dispositive Power 1,007,511.00"
pecuniary interest regulatory
"except to the extent of that person's pecuniary interest therein"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many YARW shares did the Logos reporting persons report?

Logos Global Management LP, its general partner Logos Global Management GP LLC, and William Arsani each reported 1,007,511 shares (9.99%). Logos Opportunities Fund V LP, its general partner Logos Opportunities V GP LLC, and Graham Walmsley each reported 957,511 shares (9.5%). Logos Global Master Fund LP and its general partner Logos GP LLC each reported 489,354 shares (4.9%). These are separate entries for related reporting persons.

What YARW shares and warrants were included in the reported positions?

For Logos Global and William Arsani, the reported position consists of 360,000 common shares and prefunded warrants to acquire 1,267,556 shares. For Opportunities Fund V and Graham Walmsley, it consists of 310,000 common shares and warrants to acquire 828,202 shares. For Global Master Fund, it consists of 50,000 common shares and warrants to acquire 439,354 shares. Each is subject to a 9.99% beneficial ownership limitation.

What share count was used to calculate YARW ownership percentages?

The percentages were calculated using 9,437,693 common shares outstanding following the closing of the common-stock offering described in the prospectus filed September 11, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





92941V407

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: The shares reported herein consist of 360,000 shares of Common Stock and prefunded warrants to acquire 1,267,556 shares of Common Stock, subject to a 9.99% beneficial ownership limitation. The percentage is calculated based on 9,437,693 shares of Common Stock outstanding following the closing of the offering of Common Stock reported in the Prospectus filed by the Issuer on September 11, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: The shares reported herein consist of 360,000 shares of Common Stock and prefunded warrants to acquire 1,267,556 shares of Common Stock, subject to a 9.99% beneficial ownership limitation. The percentage is calculated based on 9,437,693 shares of Common Stock outstanding following the closing of the offering of Common Stock reported in the Prospectus filed by the Issuer on September 11, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: The shares reported herein consist of 50,000 shares of Common Stock and prefunded warrants to acquire 439,354 shares of Common Stock, subject to a 9.99% beneficial ownership limitation. The percentage is calculated based on 9,437,693 shares of Common Stock outstanding following the closing of the offering of Common Stock reported in the Prospectus filed by the Issuer on September 11, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: The shares reported herein consist of 50,000 shares of Common Stock and prefunded warrants to acquire 439,354 shares of Common Stock, subject to a 9.99% beneficial ownership limitation. The percentage is calculated based on 9,437,693 shares of Common Stock outstanding following the closing of the offering of Common Stock reported in the Prospectus filed by the Issuer on September 11, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: The shares reported herein consist of 310,000 shares of Common Stock and prefunded warrants to acquire 828,202 shares of Common Stock, subject to a 9.99% beneficial ownership limitation. The percentage is calculated based on 9,437,693 shares of Common Stock outstanding following the closing of the offering of Common Stock reported in the Prospectus filed by the Issuer on September 11, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: The shares reported herein consist of 310,000 shares of Common Stock and prefunded warrants to acquire 828,202 shares of Common Stock, subject to a 9.99% beneficial ownership limitation. The percentage is calculated based on 9,437,693 shares of Common Stock outstanding following the closing of the offering of Common Stock reported in the Prospectus filed by the Issuer on September 11, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: The shares reported herein consist of 360,000 shares of Common Stock and prefunded warrants to acquire 1,267,556 shares of Common Stock, subject to a 9.99% beneficial ownership limitation. The percentage is calculated based on 9,437,693 shares of Common Stock outstanding following the closing of the offering of Common Stock reported in the Prospectus filed by the Issuer on September 11, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: The shares reported herein consist of 310,000 shares of Common Stock and prefunded warrants to acquire 828,202 shares of Common Stock, subject to a 9.99% beneficial ownership limitation. The percentage is calculated based on 9,437,693 shares of Common Stock outstanding following the closing of the offering of Common Stock reported in the Prospectus filed by the Issuer on September 11, 2026.


SCHEDULE 13G



Logos Global Management LP
Signature:/s/ Arsani William
Name/Title:Managing Partner
Date:11/16/2026
Logos Global Management GP LLC
Signature:/s/ Arsani William
Name/Title:Managing Member
Date:11/16/2026
Logos Global Master Fund LP
Signature:/s/ Arsani William
Name/Title:Managing Member of Logos GP LLC, General Partner of Logos Global Master Fund LP
Date:11/16/2026
Logos GP LLC
Signature:/s/ Arsani William
Name/Title:Managing Member
Date:11/16/2026
Logos Opportunities Fund V LP
Signature:/s/ Arsani William
Name/Title:Managing Member of Logos Opportunities V GP LLC, General Partner of Logos Opportunities Fund V LP
Date:11/16/2026
Logos Opportunities V GP LLC
Signature:/s/ Arsani William
Name/Title:Managing Member
Date:11/16/2026
Arsani William
Signature:/s/ Arsani William
Name/Title:Reporting person
Date:11/16/2026
Graham Walmsley
Signature:/s/ Graham Walmsley
Name/Title:Reporting person
Date:11/16/2026
Exhibit Information

Exhibit 99.1 - Agreement Regarding Joint Filing of Statement on Schedule 13D or 13G

Keep reading